Acute Generalized Exanthematous Pustulosis Induced by Hydroxychloroquine Prescribed for COVID-19

    June 2020 in “ The Journal of Allergy and Clinical Immunology In Practice ”
    Jérémie Delaleu, Benjamin Deniau, Maxime Battistella, Adèle de Masson, Benoît Bensaïd, M. Jachiet, Ingrid Lazaridou, M. Bagot, Jean‐David Bouaziz, Gordon L. Archer, Anne Bergeron, Anne Bergeron, Louise Bondeelle, Jean‐David Bouaziz, D. Bouda, David Boutboul, Berthon I. Brindel, Emmanuelle Bugnet, S. Caillat Zucman, S. Cassonnet, Karine Celli Lebras, Jacqueline Chabert, Sylvie Chevret, Meredith Edwards, Claire Davoine, Nathalie De Castro, É. de Kerviler, Constance de Margerie‐Mellon, Constance Delaugerre, François Dépret, B. Denis, Lalia Djaghout, Clarisse Dupin, Dominique Farge, Catherine Fauvaux, E. Feredj, Delphine Feyeux, Jean‐Sébastien Fontaine, Véronique Frémeaux‐Bacchi, Lionel Galicier, Stéphanie Harel, Jegu AL, E. Kozakiewicz, Marc Lebel, Ariane Baye, Jennifer Goff, Pierre Le Guen, Nicolas Etienne, Geoffroy Liégeon, Gwenaël Lorillon, I. Madelaine Chambrin, G. Martin de Frémont, Marie Meunier, Jean‐Michel Molina, Florence Morin, Éric Oksenhendler, Régis Peffault de Latour, Olivier Peyrony, Benoît Plaud, Maud Salmona, Julien Saussereau, Juliette Soret
    TLDR A patient developed a severe skin reaction and died after taking hydroxychloroquine for COVID-19.
    A 76-year-old male with diabetes developed acute generalized exanthematous pustulosis (AGEP) after 9 days of hydroxychloroquine (HCQ) treatment for COVID-19, which was confirmed by histological examination. The pustular eruption covered 30% of his body. Despite stopping HCQ, the patient died from a massive pulmonary embolism. The study underscored the importance of monitoring for severe skin side effects of HCQ, particularly when used off-label for COVID-19.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 7 results

      community TE turned into Scarring hairloss

      in Update  12 upvotes 8 months ago
      The user experienced hair loss due to a crash diet and later developed scarring hair loss. They are now on finasteride, oral minoxidil, LDN, Zyrtec, and Oztela to reduce scalp inflammation and promote hair regrowth.

      community Making the jump to hair systems

      in Hair Systems  27 upvotes 3 years ago
      19-year-old with Lichen Planopilaris tried various treatments unsuccessfully. Now considering hair systems, seeking experiences and opinions.

      community The Worst Hair Loss Condition You (MAY) have: LPP

      in Research/Science  43 upvotes 2 months ago
      Lichen Planopilaris (LPP) is an autoimmune condition causing permanent hair loss and fibrosis, often misdiagnosed. Treatments include pioglitazone, topical corticosteroids, anti-inflammatory medication, and Jak inhibitors.

      community Fibrosing alopecia in a pattern distribution

      in Research/Science  14 upvotes 8 months ago
      A user has been experiencing hair loss for 4 years, with treatments like minoxidil, finasteride, and various supplements proving ineffective. They were diagnosed with fibrosing alopecia in a pattern distribution, a condition that may require a combination of anti-inflammatory and hair growth treatments.

      community 5mg oral minoxidil + 100mg Spironolactone

      in Progress Pictures  10 upvotes 11 months ago
      A user shared progress pictures using 5mg oral minoxidil and 100mg spironolactone, noting increased body hair and faster nail growth. Another user humorously suggested a new sub for people with similar experiences.

    Related Research

    1 / 1 results